切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2024, Vol. 13 ›› Issue (01) : 68 -71. doi: 10.3877/cma.j.issn.2095-3232.2024.01.013

所属专题: 述评

临床研究

ICG荧光引导腹腔镜射频消融在合并严重大结节肝硬化小肝癌患者治疗中的应用
沈佳佳, 何经雄, 王芳, 江艺, 潘凡, 张小进()   
  1. 350025 福州,第九〇〇医院肝胆外科
    350025 福州,福建医科大学福总临床医学院
  • 收稿日期:2023-11-06 出版日期:2024-02-10
  • 通信作者: 张小进
  • 基金资助:
    福建省自然基金项目(2020J011136); 福建省引导性项目(2020Y0078); 联勤保障部队第九〇〇医院院内课题(2021ZD06)

Application of ICG fluorescence-guided laparoscopic radiofrequency ablation for patients with small liver cancer complicated with severe macronodular cirrhosis

Jiajia Shen, Jingxiong He, Fang Wang, Yi Jiang, Fan Pan, Xiaojin Zhang()   

  1. Department of Hepatobiliary Surgery, The 900th Hospital, Fuzhou 350025, China
    School of Clinical Medicine, Fuzhou General Hospital, Fujian Medical University, Fuzhou 350025, China
  • Received:2023-11-06 Published:2024-02-10
  • Corresponding author: Xiaojin Zhang
引用本文:

沈佳佳, 何经雄, 王芳, 江艺, 潘凡, 张小进. ICG荧光引导腹腔镜射频消融在合并严重大结节肝硬化小肝癌患者治疗中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(01): 68-71.

Jiajia Shen, Jingxiong He, Fang Wang, Yi Jiang, Fan Pan, Xiaojin Zhang. Application of ICG fluorescence-guided laparoscopic radiofrequency ablation for patients with small liver cancer complicated with severe macronodular cirrhosis[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(01): 68-71.

目的

探讨ICG荧光引导腹腔镜射频消融在合并严重大结节肝硬化小肝癌患者治疗中的应用价值。

方法

回顾性分析2021年12月至2022年6月在第九〇〇医院应用ICG荧光引导腹腔镜射频消融治疗的14例合并严重大结节肝硬化小肝癌患者临床资料。其中男13例,女1例;年龄45~82岁,中位年龄65岁。患者均签署知情同意书,符合医学伦理学规定。肿瘤均位于近肝被膜下,病灶直径0.8~3.0 cm。患者术前注射ICG,行术中荧光腹腔镜探查、肿瘤定位后再行射频消融,观察消融效果及术后恢复情况。

结果

14例均为术中肉眼难以鉴别的肿瘤与硬化结节,其中13例在多模荧光和标准荧光下能清晰鉴别肿瘤位置、边界,并顺利完成射频消融。1例术中见全肝荧光染色,无法鉴别,联合术中超声定位肿瘤后完成射频消融。14例患者术后恢复顺利,均无并发症发生,中位住院时间13 d。术后1个月复查MRI,均达到肿瘤完全消融。

结论

对于肝被膜下合并严重大结节肝硬化小肝癌患者,ICG荧光引导腹腔镜射频消融具有可靠的定位和定性诊断价值方法,是可行、有效的治疗手段。

Objective

To evaluate the application value of ICG fluorescence-guided laparoscopic radiofrequency ablation in the treatment of small liver cancer complicated with severe macronodular cirrhosis.

Methods

Clinical data of 14 small liver cancer patients complicated with severe macronodular cirrhosis treated with ICG fluorescence-guided laparoscopic radiofrequency ablation in the 900th Hospital from December 2021 to June 2022 were retrospectively analyzed. Among them, 13 patients were male and 1 female, aged from 45 to 82 years, with a median age of 65 years. The informed consents of all patients were obtained and the local ethical committee approval was received. All tumors were located adjacent to the liver capsule, and the lesion size was ranged from 0.8 to 3.0 cm in diameter. All patients were injected with ICG before surgery, received intraoperative fluorescence-guided laparoscopic exploration and tumor localization, and then underwent radiofrequency ablation. The ablation effect and postoperative recovery were observed.

Results

All 14 patients were diagnosed with indistinguishable tumors and cirrhotic nodules intraoperatively. Among them, tumor location and margin could be clearly identified under multimode and standard fluorescence in 13 cases, and they successfully completed radiofrequency ablation. Intraoperatively, fluorescence staining of the whole liver was found in 1 case, which could not be identified. Radiofrequency ablation was performed after intraoperative ultrasound localization of the tumor. 14 patients were properly recovered without complications. The median length of hospital stay was 13 d. MRI at 1 month after surgery showed that complete tumor ablation was achieved in all cases.

Conclusions

ICG fluorescence-guided laparoscopic radiofrequency ablation is a feasible and efficacy for small liver cancer patients complicated with severe macronodular cirrhosis, which yields reliable localization and qualitative diagnostic value.

图1 一例行ICG荧光导航腹腔镜射频消融术的合并严重大结节肝硬化小肝癌患者术中注:术中全肝呈荧光染色,肿瘤位置显示不清,联合术中超声完成射频治疗
图2 一例小肝癌合并严重大结节型肝硬化患者行ICG荧光导航腹腔镜射频消融术注:a示术中普通模式探查肝脏呈严重大结节型肝硬化,肉眼难以鉴别硬化结节与肿瘤;b示多模荧光与标准荧光下清晰显示肝Ⅶ、Ⅷ段肿块;c为直视下沿肿瘤按"品"字型位置消融3针,肿瘤达到完全消融
[1]
Zhou M, Wang H, Zeng X, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2019, 394(10204):1145-1158.
[2]
郑文杰, 田虎. 腹腔镜超声引导下射频消融治疗原发性小肝癌的疗效分析[J]. 腹腔镜外科杂志, 2020, 25(12):925-927, 931.
[3]
陈亚峰, 李江斌, 钟文钧, 等. 腹腔镜微波消融治疗≤3 cm肝细胞肝癌的临床疗效分析[J/OL]. 中华腔镜外科杂志(电子版), 2021, 14(5):271-276.
[4]
周善学, 陈云杰, 尹小斌, 等. 腹腔镜射频消融术与腹腔镜肝切除术治疗小肝癌的疗效对比研究[J]. 腹腔镜外科杂志, 2019, 24(4):258-262.
[5]
彭沙沙, 郭浚, 夏国兵, 等. 特殊或高危部位原发性小肝癌超声引导下腹腔镜射频消融术治疗效果及术后免疫状况分析[J]. 中华解剖与临床杂志, 2019, 24(5):458-463.
[6]
鲁葆春, 杨建辉, 唐海军, 等. 吲哚菁绿荧光实时成像联合术中超声技术在特殊部位腹腔镜肝癌切除术中的应用[J]. 肝胆胰外科杂志, 2021, 33(3):170-172, 177.
[7]
方驰华, 王晓颍, 刘允怡. 计算机辅助联合吲哚菁绿分子荧光影像技术在肝脏肿瘤诊断和手术导航中应用指南(2019版)[J]. 中国实用外科杂志, 2019, 39(7):641-650, 654.
[8]
刘永昌, 赵殿堂, 孙启峰, 等. 吲哚菁绿荧光导航和三维可视化腹腔镜精准手术治疗原发性肝癌患者应用研究[J]. 实用肝脏病杂志, 2021, 24(4):561-564.
[9]
谢国伟, 李嘉鑫, 吴泓. 吲哚氰绿荧光显像导航技术在复发性肝癌腹腔镜再次肝切除中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2020, 9(2):153-157.
[10]
Hsiao CY, Hu RH, Ho CM, et al. Surgical resection versus radiofrequency ablation for Barcelona Clinic Liver Cancer very early stage hepatocellular carcinoma: long-term results of a single-center study[J]. Am J Surg, 2020, 220(4):958-964.
[11]
Feng H, Yang C, Xu F, et al. Therapeutic efficacy of microwave coagulation versus liver resection for hepatocellular carcinoma within the Milan criteria: a propensity score matching analysis[J]. Eur J Surg Oncol, 2022, 48(2):418-424.
[12]
张发鹏, 袁荣发, 张引, 等. 腹腔镜下射频消融治疗小肝癌的临床疗效分析[J]. 中国普通外科杂志, 2018, 27(1):35-41.
[13]
邱泽成, 陈斌, 李柳生, 等. 超声引导下经皮射频消融与腹腔镜肝切除术治疗直径≤3 cm原发性肝癌的疗效分析[J]. 中国现代普通外科进展, 2019, 22(9):708-710.
[14]
徐娟, 李俊芝, 房勤茂. 超声造影联合实验室指标诊断早期肝硬化结节状小肝癌的价值[J]. 临床超声医学杂志, 2021, 23(9):698-701.
[15]
李晋, 何志唯, 陈志雄. 彩超声像图色阶在鉴别小肝癌癌结节和肝硬化假小叶结节中的价值[J]. 临床医学研究与实践, 2021, 6(31):119-121
[16]
罗建平. 探究肝硬化结节与微小肝癌应用彩超诊断与鉴别的效果[J]. 影像研究与医学应用, 2019, 3(3):24-25.
[17]
尚兴国, 张雪棉, 岳秀杰, 等. 纳米炭与吲哚箐绿荧光两种示踪法对甲状腺微小乳头状癌术中淋巴结清扫和甲状旁腺保护作用研究[J]. 标记免疫分析与临床, 2020, 27(3):423-427.
[18]
张中林, 李晓勉, 李锟, 等. 吲哚菁绿荧光成像在腹腔镜肝脏外科手术中的应用[J].中华肝胆外科杂志, 2019, 25(2):81-86.
[19]
中华医学会数字医学分会, 中国研究型医院学会数字医学临床外科专业委员会, 中国图学学会医学图像与设备专业委员会, 等. 计算机辅助联合吲哚菁绿分子荧光影像技术在肝脏肿瘤诊断和手术导航中的应用专家共识[J]. 中国实用外科杂志, 2017, 37(5):531-538.
[20]
唐啸, 岳志强, 蔡卫华, 等. ICG荧光融合影像技术在肝癌腹腔镜解剖性肝切除术中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2023, 12(1):39-43.
[21]
何攀, 苏松, 方程, 等. 吲哚菁绿荧光成像在开腹肝癌切除术中的应用分析[J]. 中华肝胆外科杂志, 2019, 25(11):809-811.
[1] 燕速, 霍博文. 腹腔镜食管胃结合部腺癌根治性切除术[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 13-13.
[2] 母德安, 李凯, 张志远, 张伟. 超微创器械辅助单孔腹腔镜下脾部分切除术[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 14-14.
[3] 李国新, 陈新华. 全腹腔镜下全胃切除术食管空肠吻合的临床研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 1-4.
[4] 李子禹, 卢信星, 李双喜, 陕飞. 食管胃结合部腺癌腹腔镜手术重建方式的选择[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 5-8.
[5] 李乐平, 张荣华, 商亮. 腹腔镜食管胃结合部腺癌根治淋巴结清扫策略[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 9-12.
[6] 陈方鹏, 杨大伟, 金从稳. 腹腔镜近端胃癌切除术联合改良食管胃吻合术重建His角对术后反流性食管炎的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 15-18.
[7] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[8] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[9] 任佳, 马胜辉, 王馨, 石秀霞, 蔡淑云. 腹腔镜全胃切除、间置空肠代胃术的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 31-34.
[10] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[11] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[12] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[13] 王庆亮, 党兮, 师凯, 刘波. 腹腔镜联合胆道子镜经胆囊管胆总管探查取石术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 313-313.
[14] 杨建辉, 段文斌, 马忠志, 卿宇豪. 腹腔镜下脾部分切除术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 314-314.
[15] 叶劲松, 刘驳强, 柳胜君, 吴浩然. 腹腔镜肝Ⅶ+Ⅷ段背侧段切除[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 315-315.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?